SBH Sciences is actively seeking partnerships to explore new therapeutic and diagnostic uses for our proprietary products and technologies.
We offer a wide range of unique products, including Activin-A, BMP-7, soluble CD22, GDF-15/MIC-1, HGF, Soluble IL-6 Receptor, and IL-23. We are the only commercial source for Natural Human GDF-15/MIC-1 and welcome partnership opportunities leveraging these specialized reagents.
We are always looking for new innovative technologies and opportunities to widen our product range and our bioassay services capabilities. If you have a novel cell line, hybridoma, or improved cell culture media you would like to license, please contact us so we can have the opportunity to make your product available to the life science community.
SBH Sciences is looking for distributors for our unique services in India, China, Japan, Eastern Europe and other countries. If your company offers other biological or chemical services worldwide, we would be very interested in hearing from you.
We seek partnerships that cultivate mutual success and foster strong relationships. Our commitment to excellence and innovative processes positions us to be an ideal partner. Whether you are interested in considering a contract, alliance, strategic partnership, or simply wish to engage in further discussions, we encourage you to contact us or schedule a visit to our facility.
SBH Diagnostics is a CLIA-certified laboratory with advanced immunological expertise, offering a rapid path to biomarker discovery, optimization, and implementation of new diagnostic tools
ABI-LAB is an accelerator and bio-incubator established to support startups and larger companies, including life science, biotech, medical technology, and medical data companies.
MedChem Partners is a medicinal chemistry service provider offering comprehensive medicinal chemistry support to biotech and pharmaceutical companies and academic laboratories engaged in research and drug discovery.
Neurodex enables precision medicine for neurodegenerative diseases by isolating cell-specific exosomes from plasma.
Bonds Biosystems provides in vitro 3D solutions to support the development of drugs for obesity and cardiometabolic diseases.